Live Breaking News & Updates on Joseph heart

Stay informed with the latest breaking news from Joseph heart on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Joseph heart and stay connected to the pulse of your community

Jack Valor Announced as SayUncle's November AllStar of the Month

SayUncle has announced Jack Valor as its AllStar of the Month for November.

Miami , Florida , United-states , Sayuncle-november , Instagram , Jack-valor-announced , November-allstar , Jack-valor , Sayuncle-allstars , Improvised-yoga-teacher , Joseph-heart , Avn

Merit Medical's WRAPSODY Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

Merit Medical's WRAPSODY Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

Brazil , Canada , United-kingdom , United-states , Rob-jones , Fredp-lampropoulos , Mahmoodk-razavi , European-union , Drug-administration , Vascular-center , Merit-medical-systems , Access-efficacy

Merit Medical's (MMSI) WRAPSODY Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

Merit Medical's (MMSI) WRAPSODY Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Canada , United-states , United-kingdom , Brazil , Mike-piccinino , Fredp-lampropoulos , Mahmoodk-razavi , Rob-jones , Systems-inc , European-union , Us-food-drug-administration , Nasdaq

Merit Medical's WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

Merit Medical's WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Brazil , United-states , South-jordan , Utah , Canada , Rob-jones , Fredp-lampropoulos , Mahmoodk-razavi , Mike-piccinino , Vascular-center , Sarah-comstock-merit-medical-systems-inc

Merit Medical's WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment - Brazil Business Today

Merit Medical's WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment - Brazil Business Today
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , United-states , South-jordan , Utah , Canada , Brazil , Mahmoodk-razavi , Fredp-lampropoulos , Mike-piccinino , Rob-jones , Sarah-comstock , Drug-administration

Merit Medical's Wrapsodytm Arteriovenous Access Efficacy (Wave) Pivotal Study Completes Enrollment

Merit Medical's Wrapsodytm Arteriovenous Access Efficacy (Wave) Pivotal Study Completes Enrollment
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Utah , United-states , Brazil , South-jordan , Canada , United-kingdom , Fredp-lampropoulos , Rob-jones , Mahmoodk-razavi , Drug-administration , Securities-exchange , Nasdaq

Vesper Medical Announces Completion of Enrollment in the VIVID Clinical Trial

Press release content from Business Wire. The AP news staff was not involved in its creation.

United-states , California , Mahmood-razavi , Andrea-dunkle , Vascular-center , Vesper-medical-inc , Stent-system , Clinical-trials , Joseph-heart , Vesper-duo-venous-stent , Vesper-medical , Chronic-venous-disease

Sirtex Medical and BlackSwan Vascular, Inc. announce first patient enrolled in pivotal LAVA Study

Share this article
Share this article
WOBURN, Mass., April 19, 2021 /PRNewswire/ -- Sirtex Medical (Sirtex), a leading manufacturer of targeted liver cancer therapies, and BlackSwan Vascular, Inc. (BlackSwan), a Bay Area-based private company developing groundbreaking therapies in endovascular embolization, announced that the first patient has been enrolled in the LAVA Study to evaluate the safety and effectiveness of the BlackSwan Lava™ liquid embolic system (LES) for the embolic treatment of arterial hemorrhage in the peripheral vasculature.
The LAVA Study, which stands for
Liquid Embolization of
Arterial Hemorrhages in Peripheral
Vasculature, is a prospective, multicenter single-arm study of 113 subjects at 20 investigational sites in the U.S. The first subject has been enrolled at the University of North Carolina School of Medicine in Chapel Hill, North Carolina, where a clinical team successfully treated a patient with a bleeding hypervascular tumor in the liver using the Lava™ LES.

Australia , California , United-states , Rush-university-medical-center , Illinois , North-carolina , University-of-north-carolina , Chapel-hill , Chicago , Sanjay-shrivastava , Bulent-arslan , Kevin-smith